Why biopharma is prioritizing data to build better medicines
Co-sponsored by:
![AWS Logo](https://cdn.prod.website-files.com/6568d65e6d1f22fd283d0100/65767a5429004f08113555dd_63ff886963515c3e52b20ca7_1280px-Amazon_Web_Services_Logo.svg.png)
We spoke with 500 biopharma executives to discover how industry leaders plan to deliver better therapeutics to patients faster. Their answer was clear. Maximize the value of scientific data with cloud-enabled FAIR data to improve three key industry drivers.
- Speed: Learning from experiments faster, reducing time-to-market for final molecules
- Cost: Improving productivity, increasing operational efficiency, increasing return on investment (ROI)
- Risk: Improving safety, reducing errors, improving compliance with regulatory requirements
Explore our key findings by downloading this infographic or see the full research report.